Glen Eagle Advisors, LLC Eli Lilly & CO Transaction History

Glen Eagle Advisors, LLC

$546 Billion
Q2 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 3,429 shares of LLY stock, worth $2.73 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

3,429

Previous 705 386.38%

Holding current value

$2.73 Million

Previous $54.5 Million 5592.33%

% of portfolio

0.57%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $1.97 Million - $2.48 Million	2,724 Added 386.38%	3,429 $3.1 Billion
Q1 2024 Jul 03, 2024	BUY	$592.2 - $792.28 $1.92 Million - $2.57 Million	3,247 New	3,247 $2.53 Billion
Q4 2023 Aug 13, 2024	SELL	$525.19 - $619.13 $82,980 - $97,822	-158 Reduced 4.94%	3,038 $1.77 Billion
Q3 2023 Aug 13, 2024	SELL	$434.7 - $599.3 $524,248 - $722,755	-1,206 Reduced 27.4%	3,196 $1.72 Billion
Q2 2023 Aug 13, 2024	BUY	$350.74 - $468.98 $32,618 - $43,615	93 Added 2.16%	4,402 $2.06 Billion
Q1 2023 Aug 13, 2024	BUY	$310.63 - $364.82 $268,694 - $315,569	865 Added 25.12%	4,309 $1.48 Billion
Q4 2022 Aug 13, 2024	BUY	$321.55 - $374.67 $398,400 - $464,216	1,239 Added 56.19%	3,444 $1.26 Billion
Q3 2022 Aug 13, 2024	BUY	$296.48 - $337.87 $366,449 - $417,607	1,236 Added 127.55%	2,205 $713 Million
Q2 2022 Aug 13, 2024	BUY	$278.73 - $327.27 $15,887 - $18,654	57 Added 6.25%	969 $314 Million
Q1 2022 Aug 13, 2024	SELL	$234.69 - $291.66 $1,642 - $2,041	-7 Reduced 0.76%	912 $261 Million
Q4 2021 Aug 13, 2024	SELL	$224.85 - $279.04 $13,940 - $17,300	-62 Reduced 6.32%	919 $254 Million
Q3 2021 Aug 13, 2024	BUY	$221.6 - $272.71 $23,489 - $28,907	106 Added 12.11%	981 $227 Million
Q1 2021 Aug 13, 2024	BUY	$164.32 - $212.72 $10,680 - $13,826	65 Added 8.02%	875 $163 Million
Q4 2020 Aug 13, 2024	SELL	$130.46 - $172.63 $317,931 - $420,699	-2,437 Reduced 75.05%	810 $137 Million
Q3 2020 Aug 13, 2024	SELL	$146.22 - $169.13 $1,315 - $1,522	-9 Reduced 1.11%	799 $118 Million
Q2 2020 Aug 13, 2024	BUY	$136.42 - $164.18 $409 - $492	3 Added 0.37%	808 $133 Million
Q1 2020 Aug 13, 2024	BUY	$119.05 - $147.35 $2,857 - $3,536	24 Added 3.07%	805 $112 Million
Q4 2019 Aug 13, 2024	BUY	$106.92 - $132.43 $8,660 - $10,726	81 Added 11.57%	781 $103 Million
Q2 2019 Aug 13, 2024	BUY	$110.79 - $129.32 $10,525 - $12,285	95 Added 15.7%	700 $77.6 Million
Q1 2019 Aug 13, 2024	SELL	$111.31 - $131.02 $294,081 - $346,154	-2,642 Reduced 81.37%	605 $78.5 Million
Q3 2018 Aug 13, 2024	SELL	$85.86 - $107.31 $8,586 - $10,731	-100 Reduced 14.18%	605 $64.9 Million
Q1 2018 Aug 14, 2024	SELL	$74.21 - $87.6 $188,641 - $222,679	-2,542 Reduced 78.29%	705 $54.5 Million
Q1 2018 Aug 13, 2024	SELL	$74.21 - $87.6 $1,261 - $1,489	-17 Reduced 2.35%	705 $54.5 Million
Q3 2017 Aug 13, 2024	SELL	$77.07 - $85.54 $194,601 - $215,988	-2,525 Reduced 77.76%	722 $61.8 Million
Q1 2017 Aug 12, 2024	SELL	N/A	-291 Reduced 28.73%	722 $60.7 Million
Q4 2016 Aug 12, 2024	SELL	N/A	-2,234	1,013 $74.5 Million

Others Institutions Holding LLY

# of Institutions

3,920

Shares Held

765M

Call Options Held

6.38M

Put Options Held

7.95M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $758B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Eli Lilly & CO Transaction History